The great escape: Viral strategies to counter BST-2/ tetherin

PLoS Pathogens

Volumn 6, Issue 5, 2010, Pages 1-12

  Douglas, Janet L ^a   Gustin, Jean K ^a   Viswanathan, Kasinath ^a   Mansouri, Mandana ^a   Moses, Ashlee V ^a   Früh, Klaus ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; CYTOKINE; MEMBRANE PROTEIN; NEF PROTEIN; PROTEIN BST 2; UBIQUITIN; UNCLASSIFIED DRUG; VPU PROTEIN; BST2 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN;

CYTOKINE PRODUCTION; EBOLA VIRUS; FILOVIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; LENTIVIRINAE; MEMBRANE STRUCTURE; MICROBIAL ACTIVITY; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION REGULATION; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; VIROLOGY; VIRUS INFECTION;

EBOLA VIRUS; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

ANTIGENS, CD; GPI-LINKED PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; MEMBRANE GLYCOPROTEINS; VIRION; VIRUS DISEASES;

EID: 77954037568     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000913     Document Type: Review

References (59)

1. Goto T, Kennel SJ, Abe M, Takishita M, Kosaka M, et al. (1994) A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood 84: 1922-1930.
2. Ishikawa J, Kaisho T, Tomizawa H, Lee BO, Kobune Y, et al. (1995) Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 26: 527-534.
3. Bartee E, McCormack A, Fruh K (2006) Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2: e107. doi:10.1371/journal.ppat.0020107.
4. Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
5. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, et al. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3: 245-252.
6. Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, et al. (2003) Bst-2/ HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4: 694-709.
7. Ohtomo T, Sugamata Y, Ozaki Y, Ono K, Yoshimura Y, et al. (1999) Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun 258: 583-591.
8. Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, et al. (2006) Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 177: 3260-3265.
9. Masuyama N, Kuronita T, Tanaka R, Muto T, Hirota Y, et al. (2009) HM1.24 is Internalized from Lipid Rafts by Clathrin-Mediated Endocytosis through Interaction with -adaptin. Journal of Biological Chemistry. pp 1-27.
10. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, et al. (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279: 827-834.
11. Rollason R, Korolchuk V, Hamilton C, Schu P, Banting G (2007) Clathrinmediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J Cell Sci 120: 3850-3858.
12. Rollason R, Korolchuk V, Hamilton C, Jepson M, Banting G (2009) A CD317/ tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. J Cell Biol 184: 721-736.
13. Cao W, Bover L, Cho M, Wen X, Hanabuchi S, et al. (2009) Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. Journal of Experimental Medicine 206: 1603-1614.
14. Willey RL, Maldarelli F, Martin MA, Strebel K (1992) Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol 66: 226-234.
15. Margottin F, Bour SP, Durand H, Selig L, Benichou S, et al. (1998) A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell 1: 565-574.
16. Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM (1990) The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol 64: 621-629.
17. Neil SJ, Eastman S, Jouvenet N, Bieniasz P (2006) HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog 2: e39. doi:10.1371/journal.ppat.0020039.
18. Miyakawa K, Ryo A, Murakami T, Ohba K, Yamaoka S, et al. (2009) BCA2/ Rabring7 promotes tetherin-dependent HIV-1 restriction. PLoS Pathog 5: e1000700. doi:10.1371/journal.ppat.1000700.
19. Perez-Caballero D, Zang T, Ebrahimi A, Mcnatt MW, Gregory DA, et al. (2009) Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells. Cell 139: 499-511.
20. Hammonds J, Wang JJ, Yi H, Spearman P (2010) Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog 6: e1000749. doi:10.1371/journal.ppat.1000749.
21. Fitzpatrick K, Skasko M, Deerinck TJ, Crum J, Ellisman MH, et al. (2010) Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles. PLoS Pathog 6: e1000701. doi:10.1371/journal.ppat.1000701.
22. Habermann A, Krijnse-Locker J, Oberwinkler H, Eckhardt M, Homann S, et al. (2010) CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J Virol 84: 4646-4658.
23. Miyagi E, Andrew AJ, Kao S, Strebel K (2009) Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci U S A 106: 2868-2873.
24. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P (2009) Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A 106: 2886-2891.
25. Andrew AJ, Miyagi E, Kao S, Strebel K (2009) The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology 6: 80.
26. Friborg J, Ladha A, Gottlinger H, Haseltine WA, Cohen EA (1995) Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J Acquir Immune Defic Syndr Hum Retrovirol 8: 10-22.
27. Schubert U, Clouse KA, Strebel K (1995) Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J Virol 69: 7699-7711.
28. Schubert U, Strebel K (1994) Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J Virol 68: 2260-2271.
29. Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, et al. (1996) The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol 70: 809-819.
30. Douglas JL, Viswanathan K, Mccarroll MN, Gustin JK, Fruh K, et al. (2009) Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a TrCP-Dependent Mechanism. J Virol 83: 7931-7947.
31. Goffinet C, Allespach I, Homann S, Tervo H, Habermann A, et al. (2009) HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor. Cell Host and Microbe 5: 285-297.
32. Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, et al. (2009) HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. Journal of Biological Chemistry. pp 1-22.
33. Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, et al. (2009) HIV-1 Vpu Neutralizes the Antiviral Factor Tetherin/BST-2 by Binding It and Directing Its Beta-TrCP2-Dependent Degradation. PLoS Pathog 5: e1000574. doi:10.1371/journal.ppat.1000574.
34. Mitchell R, Katsura C, Skasko M, Fitzpatrick K, Lau D, et al. (2009) Vpu Antagonizes BST-2-Mediated Restriction of HIV-1 Release via b-TrCP and Endo-Lysosomal Trafficking. PLoS Pathog 5: e1000450. doi:10.1371/journal.ppat.1000450.
35. Banning C, Votteler J, Hoffmann D, Koppensteiner H, Warmer M, et al. (2010) A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS ONE 5: e9344. doi:10.1371/journal.-pone.0009344.
36. Varthakavi V, Smith R, Martin K, Derdowski A, Lapierre L, et al. (2006) The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release. Traffic 7: 298-307.
37. Dubé M, Roy BB, Guiot-Guillain P, Mercier J, Binette J, et al. (2009) Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J Virol 83: 4574-4590.
38. Ruiz A, Hill MS, Schmitt K, Guatelli J, Stephens EB (2008) Requirements of the membrane proximal tyrosine and dileucine-based sorting signals for efficient transport of the subtype C Vpu protein to the plasma membrane and in virus release. Virology 378: 58-68.
39. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
40. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, et al. (2009) Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 5: e1000300. doi:10.1371/ journal.ppat.1000300.
41. Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, et al. (2009) Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2. PLoS Pathog 5: e1000429. doi:10.1371/journal.ppat.1000429.
42. Gupta R, Hué S, Schaller T, Verschoor E, Pillay D, et al. (2009) Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion. PLoS Pathog 5: e1000443. doi:10.1371/journal.ppat.1000443.
43. Rong L, Zhang J, Lu J, Pan Q, Lorgeoux R, et al. (2009) The Transmembrane Domain of BST-2 Determines Its Sensitivity to Down-Modulation by HIV-1 Vpu. J Virol. pp 1-35.
44. Lim E, Emerman M (2009) Simian immunodeficiency virus from African green monkeys (SIVAGM) does not antagonize endogenous levels of African green monkey tetherin/BST-2. J Virol. pp 1-33.
45. Wong SK, Connole M, Sullivan JS, Choe H, Carville A, et al. (2009) A New World primate deficient in tetherin-mediated restriction of human immunodeficiency virus type 1. Journal of Virology 83: 8771-8780.
46. Sato K, Yamamoto S, Misawa N, Yoshida T, Miyazawa T, et al. (2009) Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species. Retrovirology 6: 53.
47. Neil SJ, Sandrin V, Sundquist WI, Bieniasz P (2007) An interferon-alphainduced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host & Microbe 2: 193-203.
48. Sauter D, Schindler M, Specht A, Landford WN, Munch J, et al. (2009) Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 Strains. Cell Host and Microbe 6: 409-421.
49. Yang SJ, Lopez LA, Hauser H, Exline CM, Haworth KG, et al. (2010) Antitetherin activities in Vpu-expressing primate lentiviruses. Retrovirology 7: 13.
50. Bour S, Strebel K (1996) The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J Virol 70: 8285-8300.
51. Ritter GD, Yamshchikov G, Cohen SJ, Mulligan MJ (1996) Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain. J Virol 70: 2669-2673.
52. Bour S, Akari H, Miyagi E, Strebel K (2003) Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release. Virology 309: 85-98.
53. Abada P, Noble B, Cannon PM (2005) Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production. J Virol 79: 3627-3638.
54. Le Tortorec A, Neil SJD (2009) Antagonism and intracellular sequestration of human tetherin by the HIV-2 envelope glycoprotein. J Virol: 1-49.
55. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, et al. (2009) Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin Antagonists. Cell Host and Microbe: 1-14.
56. Gupta R, Mlcochova P, Pelchen-Matthews A, Petit S, Mattiuzzo G, et al. (2009) Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc Natl Acad Sci USA.
57. Mansouri M, Viswanathan K, Douglas J, Hines J, Gustin J, et al. (2009) Molecular mechanism of BST2/Tetherin downregulation by K5/MIR2 of Kaposi's sarcoma herpesvirus. J Virol.
58. Gruber M, Soding J, Lupas AN (2005) REPPER-repeats and their periodicities in fibrous proteins. Nucleic Acids Res 33: W239-243.
59. Jouvenet N, Neil SJ, Zhadina M, Zang T, Kratovac Z, et al. (2009) Broadspectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 83: 1837-1844.